Mary LozanoSEGUIRMadrid Updated: Save Send news by mail electrónicoTu name *

Your email *

email *

One of the major shortcomings of Spain in the pandemic has been the lack of sanitary material. Neither masks, nor gloves, or protective suits… For this reason, the private health sector yesterday called on the summit of the CEOE retrieve the delocalised production . “We have learned during these weeks that we depend too much on China and India. We have reindustrialise Europe and, above all, Spain in order to avoid this dependency so high,” said Martín Sellés, the president of Farmaindustria, the employers are pharmaceutical.

In this sense pronounced Juan López-Belmonte, CEO of Rovi: “It has been revealed during this crisis the need that Spain and Europe have to recover production that has been deslocalizando in asian countries. Such a high dependence on foreign countries is a risk in a field as critical as the medication”. In his view, the opportunity to do so is “historic”. For the value, health, economic and social that would have these relocations.

María Luz López-Carrasco, president of the Spanish Federation of Companies of Healthcare Technology (Fenin), indicated that it is a sector “vital” for the contribution of the technology to tackle this virus. “We have seen how companies in the sector have been working 24/7”. One of the solutions proposed was a plan for the development of a booster to the industry of healthcare technology: “We have to attract domestic and foreign investment , to create an industrial fabric where they can implement the Spanish factories, multinational companies, logistics centers, distribution… this way we will have the strategic capabilities to be able to survive other crises”.

From the pharmaceutical industry, Luis María de Palacio, president of the Business Federation of Pharmaceutical Españoles (FEFE), emphasized yesterday that they have developed their work “in an environment of maximum difficulty,” , while criticized to be carried out “policies of seizures a little erratic” and that are regulated prices in the most high demand. Without forgetting that the Administration has “ignored” . “Today we are not included in the statistics of health fallen”, he denounced.

Eduardo Pastor, president of Cofares, for his part, stressed that the industry of medication has guaranteed the supply even in the worst moments. And the president of the Alliance of the Spanish Private Health (ASPE), Carlos Rus, he did not hesitate in complaining that remain no response to obtain compensation from the Government for the activity carried out and the resources made available.